Insulin-Like Growth Factor Binding Protein 5
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Insulin-Like Growth Factor Binding Protein 5" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.
    
			
			
				
				
					
						| Descriptor ID | D018975 | 
					
						| MeSH Number(s) | D12.776.157.420.290 | 
					
						| Concept/Terms |  | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Insulin-Like Growth Factor Binding Protein 5".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Insulin-Like Growth Factor Binding Protein 5".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Insulin-Like Growth Factor Binding Protein 5" by people in this website by year, and whether "Insulin-Like Growth Factor Binding Protein 5" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2005 | 1 | 0 | 1 | 
| 2006 | 2 | 0 | 2 | 
| 2009 | 2 | 0 | 2 | 
| 2011 | 1 | 0 | 1 | 
| 2014 | 1 | 0 | 1 | 
| 2015 | 1 | 0 | 1 | 
| 2019 | 1 | 1 | 2 | 
| 2020 | 1 | 0 | 1 | 
| 2021 | 2 | 1 | 3 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Insulin-Like Growth Factor Binding Protein 5" by people in Profiles.
						
					
								- 
								Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5. Int J Mol Sci. 2021 Nov 22; 22(22). 
- 
								Single cell RNA sequencing identifies IGFBP5 and QKI as ciliated epithelial cell genes associated with severe COPD. Respir Res. 2021 Apr 06; 22(1):100. 
- 
								Chromatin Accessibility of Human Mitral Valves and Functional Assessment of MVP Risk Loci. Circ Res. 2021 03 05; 128(5):e84-e101. 
- 
								Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5. Int J Mol Sci. 2020 Dec 30; 22(1). 
- 
								Intracellular Heat Shock Protein 70 Deficiency in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2019 06; 60(6):629-636. 
- 
								NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5. Am J Physiol Lung Cell Mol Physiol. 2019 04 01; 316(4):L644-L655. 
- 
								IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF. PLoS One. 2015; 10(6):e0130546. 
- 
								The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis. PLoS One. 2014; 9(2):e87754. 
- 
								Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5. J Cell Mol Med. 2011 Apr; 15(4):957-69. 
- 
								The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms. Am J Pathol. 2009 Aug; 175(2):605-15.